Demographic and clinical characteristics (N=50):
| Variable | |
|---|---|
| Age (Years), Mean (SD) | 38.9 (13.0) |
| Gender, N(%) | |
| Female | 41 (82%) |
| Male | 9 (18%) |
| Race, N (%)* | |
| Black or African American | 21 (42%) |
| White | 17 (34%) |
| Asian | 9 (18%) |
| Other | 3 (6%) |
| Ethnicity, N (%)* | |
| Hispanic/Latino | 16 (32%) |
| Non-Hispanic/Latino | 34 (68%) |
| Education (Years), Mean (SD)* | 14.5 (2.2) |
| Disease Activity, N (%)† | |
| Asymptomatic | 13 (25%) |
| Mild/Moderate | 28 (56%) |
| Severe | 9 (18%) |
| Number of ACR criteria, Mean (SD)‡ | 6.9 (1.8) |
| Fibromyalgia Symptom Scale Total Score, Mean (SD) | 9.2 (6.4) |
| PHQ9 Total Score, Mean (SD)§ | 6.9 (5.8) |
| Length of Virtual Visit (Minutes), Mean (SD) | 14.4 (7.1) |
| Length of F2F Visit (Minutes), Mean (SD) | 15.3 (7.1) |
| Plan changed after F2F Visit, Mean (SD) | 6 (12%) |
* Race, Ethnicity, and Years of Education reported by patients† Physician determined category of disease activity‡ Based off the 1997 Revised American College of Rheumatology (ACR) criteria for Classification of SLE
§ Patient Health Questionnaire-9